11 Exenatide has been associated with hypoglycemia when given in combination with metformin, SUs, and TZDs
Average Costs of GLP-1 Medications In November 2025, Eli Lilly and Novo Nordisk agreed to drop the prices of their injectable GLP-1 medications to $350 for a months supply, and to further reduce that cost to $245 over the next two years
Regular check-ins with a healthcare provider are essential to monitor for any adverse effects
Exercise Strategies for Bone Preservation Proper exercise is crucial for maintaining bone density while on GLP-1 medications
By inhibiting glucagon production, GLP-1 receptor agonists help maintain lower blood glucose levels, preventing unwanted spikes
After approving oral Wegovy in December 2025, the FDA has now also approved Clinical trial data shows that participants taking Foundayo achieved meaningful weight loss compared with placebo, reinforcing its potential as an effective treatment option